Evidence map›Paper›PMID 22544914›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2012

Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.

Ran Jin, Ngoc-Anh Le, Shuling Liu, Monica Farkas Epperson, Thomas R Ziegler, Jean A Welsh, Dean P Jones, Craig J McClain, Miriam B Vos

Registry-linked trialOpen access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02513121 (Randomized, Controlled Dietary Treatment Study of Pediatric NAFLD), which is not on this map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02513121 nacompletednot on this mapstarted 2015, after this paper: background citation

Randomized, Controlled Dietary Treatment Study of Pediatric NAFLD

TypeinterventionalSponsorUniversity of California, San DiegoRan2015 to 2017Enrolled40ConditionsNonalcoholic Fatty Liver DiseaseArmsDietary modification
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Perspectives on youth-onset nonalcoholic fatty liver disease.Endocrinology, diabetes & metabolism · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ran JinDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Ngoc-Anh Le
Shuling Liu
Monica Farkas Epperson
Thomas R Ziegler
Jean A Welsh
Dean P Jones
Craig J McClain
Miriam B Vos
Emory University · USAtlanta VA Medical Center · USLouisville VA Medical Center · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Thioredoxin-2 protection against mitochondrial oxidative toxicityR01ES009047 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 1998 to 2013
$3.9M
Nuclear and Cytoplasmic Redox in Oxidative StressR01ES011195 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2001 to 2011
$3.3M
A metabolomic model of aging in the common marmosetR01AG038746 · NIA · EMORY UNIVERSITY · PI JONES, DEAN PAUL, PROMISLOW, DANIEL EDWARD · 2010 to 2014
$2.5M
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver DiseaseK23DK080953 · NIDDK · EMORY UNIVERSITY · PI VOS, MIRIAM B. · 2008 to 2012
$871k
Patient Oriented Research in Clinical NutritionK24RR023356 · NCRR · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 2007 to 2011
$839k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS K24 RR023356NCRR NIH HHS K24RR023356NCRR NIH HHS UL1 RR025008NCRR NIH HHS UL1RR025008NIA NIH HHS AG038746NIA NIH HHS R01 AG038746NIDDK NIH HHS K23 DK080953NIEHS NIH HHS ES009047NIEHS NIH HHS ES011195NIEHS NIH HHS R01 ES009047NIEHS NIH HHS R01 ES011195
6 · The paper itself

Abstract

contextDietary fructose induces unfavorable lipid alterations in animal models and adult studies. Little is known regarding metabolic tolerance of dietary fructose in children.

objectivesThe aim of the study was to evaluate whether dietary fructose alters plasma lipids in children with nonalcoholic fatty liver disease (NAFLD) and in healthy children. DESIGN AND

settingWe performed a 2-d, crossover feeding study at the Inpatient Clinical Interaction Site of the Atlanta Clinical and Translational Science Institute at Emory University Hospital. PARTICIPANTS AND

interventionNine children with NAFLD and 10 matched controls without NAFLD completed the study. We assessed plasma lipid levels over two nonconsecutive, randomly assigned, 24-h periods under isocaloric, isonitrogenous conditions with three macronutrient-balanced, consecutive meals and either: 1) a fructose-sweetened beverage (FB); or 2) a glucose beverage (GB) being consumed with each meal.

main outcome measuresDifferences in plasma glucose, insulin, triglyceride, apolipoprotein B, high-density lipoprotein cholesterol, and nonesterified free fatty acid levels were assessed using mixed models and 24-h incremental areas under the time-concentration curve.

resultsAfter FB, triglyceride incremental area under the curve was higher vs. after GB both in children with NAFLD (P = 0.011) and those without NAFLD (P = 0.027); however, incremental response to FB was greater in children with NAFLD than those without NAFLD (P = 0.019). For all subjects, high-density lipoprotein cholesterol declined in the postprandial and overnight hours with FB, but not with GB (P = 0.0006). Nonesterified fatty acids were not impacted by sugar but were significantly higher in NAFLD.

conclusionsThe dyslipidemic effect of dietary fructose occurred in both healthy children and those with NAFLD; however, children with NAFLD demonstrated increased sensitivity to the impact of dietary fructose.

Indexed as

AdolescentBeveragesBlood GlucoseChildCross-Over StudiesDietary CarbohydratesDisease SusceptibilityDouble-Blind MethodFatty LiverFemaleFructoseHumansInsulinLipidsMaleMetabolic DiseasesBlood GlucoseDietary CarbohydratesFructoseInsulinLipids

Identifiers

PMID22544914
PMCPMC3387406
OpenAlexW2034073943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.